Loading insider details...
Beta
Latest Form 4 (Apr 27, 2023): Disposition to Issuer of 50,000 EVFM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 27, 2023 | Evofem Biosciences, Inc. (EVFM) | Disposition to Issuer | 50,000 | n/a |
| May 31, 2022 | Evofem Biosciences, Inc. (EVFM) | Purchase | 141,000 | $49.7K |
| Feb 23, 2022 | Evofem Biosciences, Inc. (EVFM) | Grant/Award | 750,000 | n/a |
| Jan 4, 2022 | Evofem Biosciences, Inc. (EVFM) | Disposition to Issuer | 300,000 | n/a |
| Dec 20, 2021 | Evofem Biosciences, Inc. (EVFM) | Purchase | 135,000 | $50.6K |
| Jun 10, 2021 | Evofem Biosciences, Inc. (EVFM) | Purchase | 50,000 | $51.5K |
| May 21, 2021 | Evofem Biosciences, Inc. (EVFM) | Tax Withholding | 105,300 | $90.6K |
| Mar 9, 2021 | Evofem Biosciences, Inc. (EVFM) | Purchase | 45,249 | $103.2K |
| Feb 4, 2021 | Evofem Biosciences, Inc. (EVFM) | Grant/Award | 500,000 | n/a |
| Sep 11, 2020 | Evofem Biosciences, Inc. (EVFM) | Sale | 122,500 | $399.4K |